BIOMAT Database Logo BIOMAT Database Logo

Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease. 1991

A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
First Department of Internal Medicine, Osaka City University Medical School, Japan.

Plasma levels of platelet-derived growth factor (PDGF) were measured in 24 normal control subjects, 31 patients with stable angina pectoris, 25 patients with unstable angina pectoris, and 31 patients with acute myocardial infarction (AMI) by a sensitive direct radioimmunoassay. The plasma PDGF level in normal control subjects was 273 +/- 25 pg/ml; there was no significant correlation between the plasma PDGF level and age. Plasma PDGF levels in patients with unstable angina pectoris and acute myocardial infarction were significantly lower than those in normal control subjects and patients with stable angina pectoris (p less than 0.05). In patients with acute myocardial infarction the plasma PDGF level in the chronic phase was significantly higher than that in the acute phase (p less than 0.05). These observations raise the possibility that PDGF is involved in the pathophysiology of ischemic heart disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010978 Platelet Factor 4 A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C. Antiheparin Factor,CXCL4 Chemokine,Chemokine CXCL4,Heparin Neutralizing Protein,PF4 (Platelet Factor 4),gamma-Thromboglobulin,CXCL4, Chemokine,Chemokine, CXCL4,gamma Thromboglobulin
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
August 1997, Biological psychiatry,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses.
February 2005, Acta orthopaedica,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.
August 1991, Cancer research,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Serum basic fibroblast growth factor levels in patients with ischemic heart disease.
April 1997, International journal of cardiology,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Increased plasma levels of platelet-derived growth factor activity in patients with progressive systemic sclerosis.
May 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
[Plasma homocysteine levels in patients with ischemic heart disease].
July 2001, Orvosi hetilap,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
[Quantitation of platelet-bound von Willebrand factor in normal subjects and patients with coronary heart disease].
August 1991, Zhonghua xin xue guan bing za zhi,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Serum bilirubin and antioxidant levels in first degree relatives of patients with ischemic heart disease and normal subjects.
January 2011, Journal of Ayub Medical College, Abbottabad : JAMC,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
Altered plasma levels of cytokines in patients with ischemic heart disease.
January 1997, Coronary artery disease,
A Tahara, and M Yasuda, and H Itagane, and I Toda, and M Teragaki, and K Akioka, and H Oku, and K Takeuchi, and T Takeda, and S Bannai
[Plasma levels of magnesium and calcium in patients with ischemic heart disease].
February 1977, Vrachebnoe delo,
Copied contents to your clipboard!